BTIG downgraded Edwards Lifesciences (NYSE: EW) from Buy to Neutral.Dr Sean Lavin comments "When shares fell to the low $80s ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE